A Study of Teriparatide in Japanese Osteoporosis Patients

NCT01430104 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: Teriparatide
DRUG: Aspara-CA 600 mg
DRUG: Alfarol 1.0 µg

Sponsor

Eli Lilly and Company